Skip to main content

Advertisement

SpringerLink
Log in

Use depigmenting agents judiciously to lighten skin in patients with postinflammatory hyperpigmentation

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Callender VD, St Surin-Lord S, Davis E, et al. Postinflammatory hyperpigmentation: etiologic and therapeutic considerations. Am J Clin Dermatol 2011; 12(2): 87–99

    Article  PubMed  Google Scholar 

  2. Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol 2010 Jul; 3(7): 20–31

    PubMed  Google Scholar 

  3. Lowe NJ, Rizk D, Grimes P, et al. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther 1998; 20(5): 945–59

    Article  PubMed  CAS  Google Scholar 

  4. Kakita LS, Lowe NJ. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone. Clin Ther 1998; 20(5): 960–70

    Article  PubMed  CAS  Google Scholar 

  5. Cook-Bolden F. The efficacy and tolerability of combination cream containing 4% hydroquinone in the treatment of postinflammatory hyperpigmentation in skin types IV–VI. Cosmetic Dermatol 2004; 17: 149–55

    Google Scholar 

  6. Cook-Bolden FE, Hamilton SF. An open-label study of the efficacy and tolerability of microencapsulated hydroquinone 4% and retinol 0.15% with antioxidants for the treatment of hyperpigmentation. Cutis 2008; 81(4): 365–71

    PubMed  Google Scholar 

  7. Grimes PE. A microsponge formulation of hydroquinone 4% and retinol 0.15% in the treatment of melasma and postinflammatory hyperpigmentation. Cutis 2004; 74(6): 362–8

    PubMed  Google Scholar 

  8. Taylor SC, Callender VD. A multicenter, 12-week, phase 3b trial: a combination solution of mequinol 2%/tretinoin 0.01% vs hydroquinone 4% cream in the treatment of mild to moderate postinflammatory hyperpigmentation [abstract]. J Am Acad Dermatol 2006; 54 Suppl.: AB194

    Article  Google Scholar 

  9. Jacyk WK, Mpofu P. Adapalene gel 0.1 % for topical treatment of acne vulgaris in African patients. Cutis 2001; 68(4 Suppl.): 48–54

    PubMed  CAS  Google Scholar 

  10. Grimes P, Callender V Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study. Cutis 2006; 77(1): 45–50

    PubMed  Google Scholar 

  11. Bulengo-Ransby SM, Griffiths C, Kimbrough-Green CK, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med 1993; 328(20): 1438–43

    Article  PubMed  CAS  Google Scholar 

  12. Finkey MB, Herndon J, Stephens T, et al. Soy moisturizer SPF 15 improves dyschromia [poster]. J Am Acad Dermatol 2005; 52 Suppl.: P1 70

    Google Scholar 

  13. Sah A, Stephens TJ, Kurtz ES. Topical acne treatment improves postacne postinflammatory hyperpigmentation (PIH) in skin of color [poster]. J Am Acad Dermatol 2005; 52 Suppl.: P25

    Google Scholar 

  14. Levitt J. The safety of hydroquinone: a dermatologist’s response to the 2006 Federal Register. J Am Acad Dermatol 2007; 57(5): 854–72

    Article  PubMed  Google Scholar 

  15. Petit L, Pierard GE. Skin-lightening products revisited. Int J Cosmet Sci 2003; 25(4): 169–81

    Article  PubMed  CAS  Google Scholar 

  16. Grimes PE, Rendon MI, Pellerano J. Superficial chemical peels. In: Grimes PE, editor. Aesthetics and cosmetic surgery for darker skin types. Philadelphia (PA): Lippincott Williams & Wilkins, 2008: 154–69

    Google Scholar 

  17. Alster TS, Tanzi EL. Laser surgery in dark skin. Skinmed 2003; 2(2): 80–5

    Article  PubMed  Google Scholar 

  18. Antonious C, Stefanaki C. Cosmetic camouflage. J Cosmet Dermatol 2006; 5(4): 297–301

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Use depigmenting agents judiciously to lighten skin in patients with postinflammatory hyperpigmentation. Drugs Ther. Perspect 27, 10–13 (2011). https://doi.org/10.2165/11208010-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11208010-000000000-00000

Search

Navigation